Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

about

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

Item

http://www.wikidata.org/entity/Q54965558

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

@en

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

@nl

type

Item

label

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

@en

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

@nl

prefLabel

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

@en

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer.

@nl

P1476

Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer

@en

P2093

Guangrui Hu

http://www.w3.org/2001/XMLSchema#string

Jinru Xue

http://www.w3.org/2001/XMLSchema#string

Liangliang Yang

http://www.w3.org/2001/XMLSchema#string

Xiaokai Zhang

http://www.w3.org/2001/XMLSchema#string

Yue Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

Nivolumab plus ipilimumab in advanced melanoma.

Myeloid-derived suppressor cells as regulators of the immune system

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

Deficiency of CC chemokine ligand 2 and decay-accelerating factor causes retinal degeneration in mice

The epidemiology of osteosarcoma.

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.

P304

27-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JBO.2018.01.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29892522

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5993943

http://www.w3.org/2001/XMLSchema#string